Please provide your email address to receive an email when new articles are posted on . Fewer clinical deterioration events were reported in patients receiving ravulizumab (9.3%) vs. placebo (16.9%).

The authors developed and validated an accurate, well-calibrated, easy-to-implement COVID-19 hospitalized patient deterioration index to identify patients at high or low risk of clinical deterioration ...

A study conducted across seven hospitals within the Yale New Haven (Conn.) Health System found that Epic’s Deterioration Index underperformed compared to other early warning scores in detecting ...

Data on the relationship between behavioral disturbances in Alzheimer's disease (AD) and global clinical deterioration is still controversial. The purpose of this study was to explore potential ...

Dr. Michael Rothman recounts the origin of the Rothman Index and explains how overlooked nursing assessments became the key ...

Please provide your email address to receive an email when new articles are posted on . Atezolizumab plus bevacizumab did not lead to clinically meaningful deterioration in quality of life or function ...

A new study from Yale New Haven Health System — YNHHS — reveals significant differences in the performance of early warning systems designed to predict clinical deterioration in hospitalized patients.

A new study published in The Lancet Child & Adolescent Health journal suggests that parental or caregiver intuition may outperform some traditional early warning systems in identifying children at ...